Cargando…
Treatment Outcome of Endoscopic Ultrasound Radiofrequency Ablation for Incidentaloma Pancreatic Neuroendocrine Tumor in Young Female Patient: A 2-year Follow-Up
Pancreatic neuroendocrine tumors (PNETs) or islet cell tumors are neuroendocrine neoplasms that arise from cells of the endocrine and nervous system within the pancreas. Patients with PNET sometimes do not show any symptoms, known as nonfunctioning (NF) sporadic PNET. It is still debatable regarding...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830307/ https://www.ncbi.nlm.nih.gov/pubmed/36636359 http://dx.doi.org/10.1159/000526197 |
_version_ | 1784867642796933120 |
---|---|
author | Lesmana, Cosmas Rinaldi Adithya Lirendra, Mutiara Inggriani, Sri Sudoyo, Aru W. Lesmana, Laurentius |
author_facet | Lesmana, Cosmas Rinaldi Adithya Lirendra, Mutiara Inggriani, Sri Sudoyo, Aru W. Lesmana, Laurentius |
author_sort | Lesmana, Cosmas Rinaldi Adithya |
collection | PubMed |
description | Pancreatic neuroendocrine tumors (PNETs) or islet cell tumors are neuroendocrine neoplasms that arise from cells of the endocrine and nervous system within the pancreas. Patients with PNET sometimes do not show any symptoms, known as nonfunctioning (NF) sporadic PNET. It is still debatable regarding the best approach in the NF for small PNET. Currently, the surgical approach is considered the best; however, it is a highly invasive procedure, and it has a potentially high risk of complications as it requires a skilled and experienced operator. Herewith, we reported a 48-year-old female with incidentaloma of nonfunctioning PNET (NF-PNET) whose tumor has been successfully treated with endoscopic ultrasound guided radiofrequency ablation (EUSRA). There was no adverse event observed during and after the EUS procedure, and even 1 week after the procedure. One year later, abdominal magnetic resonance imaging (MRI) examination was carried out and size of the tumor was significantly getting smaller where it could hardly be seen anymore. After 2 years of follow-up, the latest abdominal MRI study showed no solid part of the tumor could be seen anymore. In conclusion, EUSRA can be an alternative option for incidentaloma of NF-PNET management. |
format | Online Article Text |
id | pubmed-9830307 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-98303072023-01-11 Treatment Outcome of Endoscopic Ultrasound Radiofrequency Ablation for Incidentaloma Pancreatic Neuroendocrine Tumor in Young Female Patient: A 2-year Follow-Up Lesmana, Cosmas Rinaldi Adithya Lirendra, Mutiara Inggriani, Sri Sudoyo, Aru W. Lesmana, Laurentius Case Rep Gastroenterol Single Case Pancreatic neuroendocrine tumors (PNETs) or islet cell tumors are neuroendocrine neoplasms that arise from cells of the endocrine and nervous system within the pancreas. Patients with PNET sometimes do not show any symptoms, known as nonfunctioning (NF) sporadic PNET. It is still debatable regarding the best approach in the NF for small PNET. Currently, the surgical approach is considered the best; however, it is a highly invasive procedure, and it has a potentially high risk of complications as it requires a skilled and experienced operator. Herewith, we reported a 48-year-old female with incidentaloma of nonfunctioning PNET (NF-PNET) whose tumor has been successfully treated with endoscopic ultrasound guided radiofrequency ablation (EUSRA). There was no adverse event observed during and after the EUS procedure, and even 1 week after the procedure. One year later, abdominal magnetic resonance imaging (MRI) examination was carried out and size of the tumor was significantly getting smaller where it could hardly be seen anymore. After 2 years of follow-up, the latest abdominal MRI study showed no solid part of the tumor could be seen anymore. In conclusion, EUSRA can be an alternative option for incidentaloma of NF-PNET management. S. Karger AG 2022-11-07 /pmc/articles/PMC9830307/ /pubmed/36636359 http://dx.doi.org/10.1159/000526197 Text en Copyright © 2022 by The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission. |
spellingShingle | Single Case Lesmana, Cosmas Rinaldi Adithya Lirendra, Mutiara Inggriani, Sri Sudoyo, Aru W. Lesmana, Laurentius Treatment Outcome of Endoscopic Ultrasound Radiofrequency Ablation for Incidentaloma Pancreatic Neuroendocrine Tumor in Young Female Patient: A 2-year Follow-Up |
title | Treatment Outcome of Endoscopic Ultrasound Radiofrequency Ablation for Incidentaloma Pancreatic Neuroendocrine Tumor in Young Female Patient: A 2-year Follow-Up |
title_full | Treatment Outcome of Endoscopic Ultrasound Radiofrequency Ablation for Incidentaloma Pancreatic Neuroendocrine Tumor in Young Female Patient: A 2-year Follow-Up |
title_fullStr | Treatment Outcome of Endoscopic Ultrasound Radiofrequency Ablation for Incidentaloma Pancreatic Neuroendocrine Tumor in Young Female Patient: A 2-year Follow-Up |
title_full_unstemmed | Treatment Outcome of Endoscopic Ultrasound Radiofrequency Ablation for Incidentaloma Pancreatic Neuroendocrine Tumor in Young Female Patient: A 2-year Follow-Up |
title_short | Treatment Outcome of Endoscopic Ultrasound Radiofrequency Ablation for Incidentaloma Pancreatic Neuroendocrine Tumor in Young Female Patient: A 2-year Follow-Up |
title_sort | treatment outcome of endoscopic ultrasound radiofrequency ablation for incidentaloma pancreatic neuroendocrine tumor in young female patient: a 2-year follow-up |
topic | Single Case |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830307/ https://www.ncbi.nlm.nih.gov/pubmed/36636359 http://dx.doi.org/10.1159/000526197 |
work_keys_str_mv | AT lesmanacosmasrinaldiadithya treatmentoutcomeofendoscopicultrasoundradiofrequencyablationforincidentalomapancreaticneuroendocrinetumorinyoungfemalepatienta2yearfollowup AT lirendramutiara treatmentoutcomeofendoscopicultrasoundradiofrequencyablationforincidentalomapancreaticneuroendocrinetumorinyoungfemalepatienta2yearfollowup AT inggrianisri treatmentoutcomeofendoscopicultrasoundradiofrequencyablationforincidentalomapancreaticneuroendocrinetumorinyoungfemalepatienta2yearfollowup AT sudoyoaruw treatmentoutcomeofendoscopicultrasoundradiofrequencyablationforincidentalomapancreaticneuroendocrinetumorinyoungfemalepatienta2yearfollowup AT lesmanalaurentius treatmentoutcomeofendoscopicultrasoundradiofrequencyablationforincidentalomapancreaticneuroendocrinetumorinyoungfemalepatienta2yearfollowup |